GSK To Update FDA On HPV Vaccine Cervarix Later This Year, CEO Says

GlaxoSmithKline CEO Jean-Pierre Garnier on Thursday said that the company will provide FDA with updated information about its human papillomavirus vaccine Cervarix by the third quarter of 2008, Reuters reports.

More: continued here

Filed under: Cervical Cancer on February 13th, 2008